Feyza Engin

Title: Feyza Engin: Innovator in Metabolic Disorder Treatments

Introduction

Feyza Engin is a prominent inventor based in Madison, WI (US), known for her significant contributions to the field of metabolic disorders. With a focus on innovative treatments, she has developed groundbreaking solutions that target critical health issues such as diabetes and obesity. Her work has led to the filing of three patents, showcasing her commitment to advancing medical science.

Latest Patents

One of her latest patents is centered around anti-AP2 antibodies and antigen binding agents designed to treat metabolic disorders. This invention focuses on improved anti-aP2 antibodies and compositions that target the lipid chaperone aP2/FABP4. These agents are intended for use in treating various disorders, including diabetes, obesity, cardiovascular disease, fatty liver disease, and cancer. The patent outlines methods for neutralizing or modulating the biological activity of aP2 using low-binding affinity monoclonal antibodies. This innovative approach aims to provide lower fasting blood glucose levels, enhance systemic glucose metabolism, increase insulin sensitivity, and reduce fat mass and liver steatosis, ultimately lowering the risk of cardiovascular disease.

Career Highlights

Feyza Engin has worked with esteemed institutions such as Harvard College and UCB Biopharma. Her experience in these organizations has contributed to her expertise in the field of metabolic disorders and has facilitated her innovative research.

Collaborations

Throughout her career, she has collaborated with notable professionals, including Gökhan S Hotamisligil and Mehmet F Burak. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Feyza Engin's work in developing anti-AP2 antibodies represents a significant advancement in the treatment of metabolic disorders. Her innovative approach and dedication to research continue to pave the way for improved health outcomes.